Delivery Order SPE2DB20D1109-SPE2DB23FN72D
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,034.80 for the supply of XEOMIN 200 unit vials. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics support to the U.S. military. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,560,989,038 units of XEOMIN 200 UNIT VIALS. The contract has a firm fixed price and a ceiling value of $4,193.92. The award date is May 18, 2023, and the ultimate completion date is June 9, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $86,177.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order for the supply of 4,559,517,536 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract has an Ultimate Completion Date of September 12, 2022 and was awarded on August 19, 2022. This award is not associated with a set-aside designation, indicating open competition....
- This federal contract award, valued at $2,279.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XEOMIN 50 unit vials, a pharmaceutical product, and has a completion date of January 29, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
- This federal contract award, valued at $1,048.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,561,893,648 units of XEOMIN 100 UNIT VIALS, a specialty medication. The award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This contract award is for the delivery of 4,566,711,466 units of the pharmaceutical drug XEOMIN (200 unit vials) to the Defense Logistics Agency (DLA). The $10,847.20 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024, with a completion date of January 6, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $4,103.68 for the supply of 4,558,237,997 units of XEOMIN 200 unit vials. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have any set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,252,859 units of the drug XEOMIN (200 unit vials). The firm-fixed-price contract has a ceiling value of $1,117.48 and an ultimate completion date of June 4, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
- This federal contract award is a delivery order worth $4,193.92 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA). The contract is for the delivery of 4,560,572,353 units of XEOMIN 200 unit vials, a pharmaceutical product, with a period of performance through May 3, 2023. This award is not designated as a set-aside and was competitively awarded. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $7,694.40 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 200-unit vials of the drug Xeomin. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FN72DDelivery Order
This federal contract award, valued at $5,242.40, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4560262540 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The awarded delivery order has a firm fixed price and a completion date of April 4, 2023. The contract was awarded on an unrestricted, full and open competition basis, with no set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 3/14/23 |